Laporan Laba Rugi (TTM)
Laporan Laba Rugi Tikun Olam-Cannbit Pharmaceuticals Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 | 22 | 25 | 28 | 32 | 37 | 39 | 41 | 45 | 49 | 50 | 51 | 47 | 44 | 43 | 43 | 39 | 35 |
| Change (%) | 33.40 | 14.30 | 12.51 | 16.47 | 14.14 | 5.59 | 5.30 | 9.87 | 8.98 | 1.40 | 1.38 | -6.37 | -6.80 | -1.90 | -1.94 | -8.92 | -9.80 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 5 | 7 | 9 | 11 | 20 | 29 | 32 | 35 | 33 | 31 | 32 | 32 | 33 | 33 | 36 | 39 | 34 | 30 |
| Change (%) | 46.97 | 22.79 | 18.56 | 86.87 | 46.49 | 10.39 | 9.41 | -6.05 | -6.44 | 2.03 | 1.99 | 0.37 | 0.37 | 9.44 | 8.62 | -12.02 | -13.66 | |
| % of Revenue | 30.89 | 34.04 | 36.56 | 38.53 | 61.82 | 79.34 | 82.94 | 86.19 | 73.70 | 63.27 | 63.66 | 64.04 | 68.65 | 73.94 | 82.48 | 91.37 | 88.26 | 84.48 |
| Gross Operating Profit | 11 | 14 | 16 | 17 | 12 | 8 | 7 | 6 | 12 | 18 | 18 | 18 | 15 | 12 | 8 | 4 | 5 | 5 |
| Change (%) | 27.34 | 9.93 | 9.03 | -27.66 | -38.23 | -12.84 | -14.73 | 109.19 | 52.20 | 0.32 | 0.32 | -18.37 | -22.50 | -34.07 | -51.67 | 23.85 | 19.26 | |
| % of Revenue | 69.11 | 65.96 | 63.44 | 61.47 | 38.18 | 20.66 | 17.06 | 13.81 | 26.30 | 36.73 | 36.34 | 35.96 | 31.35 | 26.06 | 17.52 | 8.63 | 11.74 | 15.52 |
| SG&A | 27 | 29 | 29 | 29 | 28 | 28 | 26 | 24 | 24 | 24 | 25 | 25 | 24 | 23 | 21 | 19 | 16 | 13 |
| Change (%) | 8.87 | 0.72 | 0.71 | -2.77 | -2.85 | -6.38 | -6.82 | -0.38 | -0.38 | 3.19 | 3.10 | -5.21 | -5.49 | -8.89 | -9.76 | -16.37 | -19.57 | |
| % of Revenue | 163.30 | 133.27 | 117.43 | 105.11 | 87.75 | 74.68 | 66.22 | 58.60 | 53.14 | 48.57 | 49.43 | 50.27 | 50.89 | 51.60 | 47.93 | 44.10 | 40.50 | 36.11 |
| R&D | 2 | 2 | 3 | 4 | 6 | 7 | 7 | 6 | 6 | 5 | 6 | 7 | 5 | 4 | 3 | 1 | 1 | 1 |
| Change (%) | 26.62 | 45.78 | 31.40 | 37.15 | 27.09 | -8.74 | -9.58 | -6.55 | -7.01 | 16.26 | 13.99 | -21.54 | -27.45 | -30.91 | -44.74 | -22.01 | -28.21 | |
| % of Revenue | 10.48 | 9.95 | 12.69 | 14.82 | 17.45 | 19.43 | 16.79 | 14.42 | 12.27 | 10.47 | 12.00 | 13.49 | 11.30 | 8.80 | 6.20 | 3.49 | 2.99 | 2.38 |
| OpEx | 41 | 54 | 61 | 68 | 74 | 80 | 79 | 78 | 77 | 76 | 107 | 138 | 105 | 72 | 108 | 86 | 39 | 50 |
| Change (%) | 31.47 | 12.86 | 11.40 | 9.03 | 8.48 | -1.40 | -1.23 | -1.31 | -1.71 | 41.47 | 29.31 | -23.96 | -31.51 | 50.34 | -20.32 | -55.09 | 27.70 | |
| % of Revenue | 252.29 | 248.64 | 245.51 | 243.07 | 227.53 | 216.25 | 201.93 | 189.41 | 170.14 | 153.44 | 214.06 | 273.04 | 221.72 | 162.93 | 249.69 | 202.88 | 100.05 | 141.63 |
| Operating Income | -25 | -32 | -36 | -40 | -41 | -43 | -40 | -37 | -32 | -26 | -57 | -88 | -58 | -28 | -65 | -44 | -0 | -15 |
| Change (%) | 30.20 | 11.89 | 10.63 | 3.82 | 4.04 | -7.41 | -7.63 | -13.82 | -16.96 | 116.45 | 53.80 | -34.13 | -51.82 | 133.35 | -32.60 | -99.96 | 80,744.44 | |
| % of Revenue | -152.29 | -148.64 | -145.51 | -143.07 | -127.53 | -116.25 | -101.93 | -89.41 | -70.14 | -53.44 | -114.06 | -173.04 | -121.72 | -62.93 | -149.69 | -102.88 | -0.05 | -41.63 |
| Interest Expense | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 |
| Change (%) | 52.66 | 11.05 | 9.95 | -5.95 | -6.33 | 14.06 | 12.33 | 3.87 | 3.73 | 7.53 | 7.00 | 6.59 | 6.18 | -5.00 | -5.26 | -4.54 | -4.75 | |
| % of Revenue | -4.80 | -5.49 | -5.34 | -5.22 | -4.21 | -3.46 | -3.73 | -3.98 | -3.77 | -3.58 | -3.80 | -4.01 | -4.57 | -5.20 | -5.04 | -4.87 | -5.10 | -5.39 |
| Net Income | -27 | -33 | -34 | -35 | -34 | -33 | -30 | -27 | -38 | -48 | -77 | -107 | -98 | -89 | -69 | -50 | -45 | -40 |
| Change (%) | 24.03 | 3.35 | 3.24 | -3.55 | -3.68 | -8.74 | -9.58 | 39.52 | 28.33 | 60.61 | 37.74 | -8.35 | -9.11 | -21.85 | -27.95 | -9.94 | -11.04 | |
| % of Revenue | -163.58 | -152.09 | -137.52 | -126.19 | -104.49 | -88.17 | -76.20 | -65.44 | -83.10 | -97.85 | -154.98 | -210.55 | -206.09 | -200.97 | -160.11 | -117.64 | -116.33 | -114.73 |
Source: Capital IQ
